End-of-day quote
Other stock markets
|
||
- USD | - |
|
2015 | AbbVie : Merck says hepatitis C drugs to lose breakthrough status | RE |
2014 | Apple : Wall St. edges up, lifted by mergers, acquisitions | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Teresa Dahlman
IRC | Investor Relations Contact | - | - |
Michele Liuzzi
PRN | Corporate Officer/Principal | - | - |
Adel Moussa
PRN | Corporate Officer/Principal | - | 01/02/01 |
John Mao
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,503,782 | 117,733,252 ( 77.71 %) | 0 | 77.71 % |
Company contact information
![address Idenix Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/9634.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- Stock
- Company Idenix Pharmaceuticals Inc